Literature DB >> 16273510

Germ cell lineage differentiation in non-seminomatous germ cell tumours.

Friedemann Honecker1, Hans Stoop, Frank Mayer, Carsten Bokemeyer, Diego H Castrillon, Yun-Fai Chris Lau, Leendert H J Looijenga, J Wolter Oosterhuis.   

Abstract

Human germ cell tumours (GCTs) have long fascinated investigators for a number of reasons. Being pluripotential tumours, they can differentiate into both extra-embryonic and embryonic (somatic) tissues. However, it has never been shown convincingly that, in humans, these tumours are truly totipotent and can also give rise to the germ lineage, the third major differentiation lineage occurring early during embryonic life. Using a number of newly available, distinct, immunohistochemical markers, such as OCT3/4, VASA and TSPY, the occurrence of germ cells was investigated in a number of germ cell tumours. Development of germ cells was identified in three independent non-seminomas, including two pure yolk sac tumours and one mixed tumour composed of yolk sac tumour and immature teratoma. Our finding indicates a previously unknown totipotent potential of human GCTs and raises the question of whether, under certain culture conditions, primordial germ cells could be derived from human GCT cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16273510     DOI: 10.1002/path.1872

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  21 in total

1.  Totipotency: what it is and what it is not.

Authors:  Maureen L Condic
Journal:  Stem Cells Dev       Date:  2014-02-12       Impact factor: 3.272

2.  HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma.

Authors:  Siyi Wanggou; Xingjun Jiang; Qiaoyu Li; Lihua Zhang; Dingyang Liu; Guifei Li; Xiangling Feng; Weidong Liu; Bin Zhu; Wei Huang; Jia Shi; Xianrui Yuan; Caiping Ren
Journal:  J Neurooncol       Date:  2011-08-23       Impact factor: 4.130

Review 3.  Testicular cancer: biology and biomarkers.

Authors:  Leendert H J Looijenga; Hans Stoop; Katharina Biermann
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

4.  Stem cell origin of testicular seminoma.

Authors:  Avik Som; Sijin Wen; Shi-Ming Tu
Journal:  Clin Genitourin Cancer       Date:  2013-07-10       Impact factor: 2.872

5.  Insights on neoplastic stem cells from gel-based proteomics of childhood germ cell tumors.

Authors:  William E Haskins; Sruthi Eedala; Y L Avinash Jadhav; Manbir S Labhan; Vidya C Pericherla; Elizabeth J Perlman
Journal:  Pediatr Blood Cancer       Date:  2011-07-26       Impact factor: 3.167

6.  The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors.

Authors:  Yunmin Li; Z Laura Tabatabai; Tin-Lap Lee; Shingo Hatakeyama; Chikara Ohyama; Wai-Yee Chan; Leendert H J Looijenga; Yun-Fai Chris Lau
Journal:  Hum Pathol       Date:  2007-05-22       Impact factor: 3.466

Review 7.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

Review 8.  Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis.

Authors:  Jenny E Elzinga-Tinke; Gert R Dohle; Leendert Hj Looijenga
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

9.  Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle.

Authors:  Ad J M Gillis; Martin A Rijlaarsdam; Ronak Eini; Lambert C J Dorssers; Katharina Biermann; Matthew J Murray; James C Nicholson; Nicholas Coleman; Klaus-Peter Dieckmann; Gazanfer Belge; Jörn Bullerdiek; Tom Xu; Nathalie Bernard; Leendert H J Looijenga
Journal:  Mol Oncol       Date:  2013-08-20       Impact factor: 6.603

Review 10.  Molecular Biology of Pediatric and Adult Male Germ Cell Tumors.

Authors:  Mariana Tomazini Pinto; Flavio Mavignier Cárcano; Ana Glenda Santarosa Vieira; Eduardo Ramos Martins Cabral; Luiz Fernando Lopes
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.